Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.

Marlon Lakmal PereraJohn El KhouryVidyasagar ChinniDamien BoltonLiang QuPaul JohnsonJason A TrublanoChristine F McDonaldDaryl JonesRinaldo BellomoOneel PatelJoseph Ischia

Published in: BMJ open (2020)

ACTRN126200000454976.

Keyphrases

sars cov
high dose
study protocol
randomized controlled trial
stem cell transplantation
low dose
respiratory syndrome coronavirus
coronavirus disease
clinical trial
phase iii
phase ii
open label
stem cells
mesenchymal stem cells
smoking cessation